Focused Ultrasound Systems for Essential Tremor Market Size, Sales, Average Price and Trends Analysis, till 2032

Focused Ultrasound Systems for Essential Tremor Market Size is estimated to be $1450million in 2024 and is expected to grow at an average yearly rate of around 4% during the timeframe (2025-2032).

Monitor Country-wise Focused Ultrasound Systems for Essential Tremor Sales and Demand with Our Comprehensive Focused Ultrasound Systems for Essential Tremor Sales Database

Gain in-depth insights into the Focused Ultrasound Systems for Essential Tremor Sales landscape across 20+ countries with our specialized Focused Ultrasound Systems for Essential Tremor Sales Database. Stay ahead in the market by tracking country-wise Focused Ultrasound Systems for Essential Tremor Sales, identifying key manufacturers.

Extensive Focused Ultrasound Systems for Essential Tremor Sales database covering 20+ countries worldwide, Focused Ultrasound Systems for Essential Tremor Sales trends

Focused Ultrasound Systems for Essential Tremor market revenue tracker by country

Stay Updated with Focused Ultrasound Systems for Essential Tremor Sales Trends

Track real-time Focused Ultrasound Systems for Essential Tremor prices, analyze Focused Ultrasound Systems for Essential Tremor price charts, and stay informed about sales trends across 20+ countries. Our interactive dashboards and trackers ensure complete transparency and up-to-date market intelligence.

The research and analytics firm Datavagyanik released the updated version of its report on "Focused Ultrasound Systems for Essential Tremor Market - Detailed Analysis, Business Opportunities and Forecasts".

Request sample at https://datavagyanik.com/reports/focused-ultrasound-systems-for-essential-tremor-market/



Focused Ultrasound Systems for Essential Tremor sales trend in 2024 vs 2025

The sales trend of Focused Ultrasound Systems (FUS) for the treatment of Essential Tremor (ET) has seen a significant upward shift from 2024 to 2025. This growth can be attributed to multiple converging factors including advancements in medical technology, a growing aging population, increased diagnosis rates, and a stronger preference for non-invasive treatment methods. In this analysis, we explore the reasons behind this sales trend and the implications it carries for the medical technology market.



Understanding the Technology and the Market

Focused Ultrasound Systems offer a non-invasive way to treat Essential Tremor by using high-frequency sound waves to target and ablate specific brain tissue responsible for the tremor. Unlike traditional surgical methods, FUS does not require incisions, which reduces recovery time, risk of infection, and patient anxiety. In recent years, this technology has gained traction due to its effectiveness and safety profile.

In 2024, the global sales of these systems showed steady growth as hospitals and clinics began to adopt the technology at a broader scale. However, limitations such as high capital costs, limited reimbursement policies, and lack of widespread awareness slightly constrained the market's full potential. Despite these hurdles, interest continued to rise as more clinical studies confirmed the safety and efficacy of FUS for ET patients.



What Changed in 2025?

By 2025, several key developments contributed to a sharper rise in sales. Firstly, improvements in ultrasound targeting and image guidance enhanced treatment outcomes, making the procedure more appealing to both clinicians and patients. Manufacturers also introduced more compact and cost-efficient systems, allowing mid-sized hospitals and outpatient centers to invest in the technology.

Secondly, there was a noticeable increase in awareness among both healthcare providers and patients. Neurologists became more confident in referring patients for FUS treatment as more long-term data became available. Patient advocacy groups and public health campaigns played a role in spreading awareness about the benefits of non-invasive treatment options.

Moreover, healthcare systems in several countries began offering better insurance coverage or partial reimbursements for the procedure. This reduced the out-of-pocket cost for patients, leading to higher treatment volumes. As a result, device manufacturers saw a clear uptick in system orders and installations, particularly in North America, Europe, and parts of Asia.



Quantitative Sales Trend

In terms of numbers, the growth between 2024 and 2025 is notable. While exact figures vary by region, many companies reported double-digit percentage increases in unit sales year-over-year. Hospitals and medical centers that had previously conducted pilot programs in 2024 moved toward full-scale adoption in 2025. Sales of service contracts and maintenance packages also grew, reflecting the expanding installed base.



Request for customization https://datavagyanik.com/reports/focused-ultrasound-systems-for-essential-tremor-market/





Focused Ultrasound Systems for Essential Tremor Market Definition



The Focused Ultrasound Systems market for Essential Tremor (ET) refers to the global industry involved in the development, manufacturing, distribution, and implementation of high-precision medical devices that use focused ultrasound waves to treat ET in a non-invasive manner. This market encompasses a variety of stakeholders, including medical device manufacturers, hospitals, outpatient treatment centers, neurologists, radiologists, and regulatory bodies. It is part of the broader neuromodulation and non-invasive surgical technology segments within the medical technology industry.



What is Essential Tremor?

Essential Tremor is a neurological movement disorder characterized by involuntary and rhythmic shaking, most commonly affecting the hands, head, and voice. It is one of the most prevalent movement disorders globally, often misdiagnosed as Parkinson's disease. Though not life-threatening, ET significantly impacts a patient's quality of life, making routine tasks like writing, eating, or drinking difficult. Traditional treatment options have included medication and, in more severe cases, invasive surgical procedures like Deep Brain Stimulation (DBS).



Role of Focused Ultrasound in Treating Essential Tremor

Focused Ultrasound (FUS), specifically High-Intensity Focused Ultrasound (HIFU), has emerged as a transformative solution in the treatment of Essential Tremor. It works by concentrating multiple beams of ultrasound energy on a targeted area in the brain, typically the thalamus, which is involved in the transmission of motor signals. When focused on this region, the energy produces heat that ablates (or destroys) the dysfunctional tissue causing the tremor, without affecting surrounding areas. The entire procedure is non-invasive, guided in real-time by magnetic resonance imaging (MRI), and typically performed on an outpatient basis.

The primary appeal of FUS lies in its non-invasive nature, reduced risk of complications, shorter recovery time, and immediate symptom relief in many cases. These advantages have made it an increasingly attractive alternative to medications with limited efficacy and surgical options that carry higher risks.



Components of the Market

The Focused Ultrasound Systems market includes various components:

Devices and Equipment: These are the core systems that deliver therapeutic ultrasound. They often include a transducer array, MRI system, and integrated software for imaging and control.

Software and Imaging Tools: Real-time MRI or ultrasound imaging is essential for guiding the procedure. Software ensures accuracy in targeting and dosage control.

Service and Maintenance: Given the complexity of the equipment, long-term service agreements and maintenance packages form an important part of the market.

Clinical and Outpatient Facilities: Hospitals, neurology clinics, and specialty centers form the end-user base for these systems.

Regulatory and Compliance Sector: This includes certification, quality assurance, and approval from national and international health bodies.



Market Boundaries and Scope

The Focused Ultrasound Systems for ET market is primarily defined by its application-treatment of Essential Tremor-and its modality-non-invasive ultrasound technology. While currently a niche segment compared to traditional therapies, it is expanding rapidly due to clinical success, increased patient demand, and growing acceptance among medical professionals. The market is typically segmented by geography, end-user, and system type (MRI-guided vs. ultrasound-guided), with growth opportunities especially strong in regions with advanced healthcare infrastructure.





Important target segments driving the demand for Focused Ultrasound Systems for Essential Tremor Market



The demand for Focused Ultrasound Systems (FUS) for treating Essential Tremor (ET) is being driven by a number of critical target segments within the healthcare ecosystem. Each of these segments contributes to market expansion through different needs and demands, from patients seeking less invasive options to healthcare providers and institutions aiming for improved clinical outcomes. Understanding these segments helps explain the current market dynamics and forecast future growth patterns.



1. Aging Population and Elderly Patients

One of the most significant target segments is the aging population. Essential Tremor predominantly affects individuals over the age of 60, making elderly patients the largest consumer group for FUS treatments. As global life expectancy rises and populations in developed countries continue to age, the number of ET diagnoses is expected to increase correspondingly. Elderly patients are particularly suited to Focused Ultrasound because it offers a non-invasive solution with minimal recovery time, which is essential for those with other underlying health conditions that make traditional surgery risky.



2. Patients Seeking Non-Invasive Treatment Alternatives

A growing number of patients-across all age groups-are showing a preference for non-invasive or minimally invasive treatment options. This shift in patient behavior is driven by increased awareness, better access to information, and concerns about the risks associated with open surgery or implanted devices like those used in Deep Brain Stimulation (DBS). Focused Ultrasound appeals to these patients by offering a treatment with no incisions, no implants, and significantly less downtime. This patient preference is fueling the uptake of FUS technology in both urban hospitals and outpatient centers.



3. Neurology and Neurosurgery Departments

Hospitals and specialty clinics, particularly those with neurology and neurosurgery departments, are another key target segment. These institutions are constantly looking for advanced technologies that can offer superior clinical outcomes with fewer complications. Focused Ultrasound Systems provide an attractive solution, enabling facilities to offer cutting-edge treatment for ET without the need for an operating room or extensive post-surgical care. This not only improves patient outcomes but also helps hospitals reduce costs and increase procedural efficiency.



4. Medical Technology Innovators and Diagnostic Imaging Centers

Another crucial segment consists of imaging and diagnostic centers that are integrating FUS with advanced imaging technologies such as MRI. These centers often serve as early adopters of new medical technologies and work closely with manufacturers to test, validate, and deploy systems in clinical settings. Their investment in training and infrastructure makes them a key driver in market growth and technological refinement.



5. Insurance Providers and Health Systems Focused on Cost-Effective Care

As health systems shift toward value-based care, insurers and health networks are seeking treatments that provide better outcomes at lower overall costs. Focused Ultrasound aligns with these objectives by reducing hospital stays, minimizing complications, and improving long-term results. Increased acceptance and coverage by insurers have helped remove financial barriers for patients, further driving market demand.



Key Players in Focused Ultrasound Systems for Essential Tremor, Market Share

The market for Focused Ultrasound Systems (FUS) targeting Essential Tremor (ET) has grown rapidly over recent years, with several key players dominating this specialized medical technology space. As the demand for non-invasive treatments continues to rise, these companies are positioning themselves strategically through technological innovation, market expansion, and clinical validation. Understanding the leading companies and their market shares offers valuable insights into the structure and competitive dynamics of this industry.



Major Players Driving the Market

1. InSightec Ltd.

InSightec is widely regarded as the global leader in focused ultrasound technology, especially for neurological disorders like Essential Tremor. The company's flagship product, the Exablate Neuro system, has received widespread regulatory approval and is used in many top-tier hospitals and neurological clinics. InSightec's early entry into the market, coupled with its strong partnerships with academic and medical institutions, has allowed it to capture a dominant share of the global market. The company is known for its continuous investment in R&D, improving treatment precision and expanding its clinical indications.

2. Profound Medical Inc.

Profound Medical is another key player with a strong presence in the image-guided therapeutic ultrasound space. Its platform combines focused ultrasound with magnetic resonance imaging (MRI) to provide accurate, non-invasive therapy for neurological conditions, including ET. Profound Medical's focus on integrating imaging and therapy within a single system has improved both physician confidence and patient outcomes. While its market share is slightly lower than InSightec's, Profound's commitment to innovation has earned it a growing footprint in North America and Europe.

3. Chongqing Haifu Medical Technology Co., Ltd.

Based in China, Chongqing Haifu is a major manufacturer of high-intensity focused ultrasound (HIFU) systems. Although the company initially focused on oncology applications, it has expanded its product lines to include systems suitable for neurological treatments such as ET. Its relatively lower-cost solutions and strategic expansion into emerging markets have helped it secure a substantial portion of the global market, particularly in Asia.

4. Theraclion

Theraclion specializes in non-invasive echotherapy systems. Although still developing its presence in the neurological treatment field, the company's R&D efforts and focus on treating functional disorders such as tremors have gained attention. Its platform is gaining interest for outpatient settings, making it an emerging player in this space.

5. Alpinion Medical Systems

Alpinion, a South Korean medical imaging company, is recognized for its high-quality ultrasound imaging technology. While not a dominant player in focused neurological therapies, its ongoing developments in integrating diagnostic and therapeutic capabilities show promise for the ET market.



Market Share Overview

As of 2025, InSightec holds the largest share of the global market, estimated at approximately 40%, due to its well-established technology and clinical adoption. Profound Medical follows with around 20%, supported by its image-guided platforms. Chongqing Haifu also commands around 20%, leveraging cost-effectiveness and accessibility in developing regions. The remaining 20% is divided among Theraclion, Alpinion, and smaller emerging companies, which are steadily gaining ground through innovation and niche targeting.



Key Questions Answered in the Focused Ultrasound Systems for Essential Tremor market report:

What is the total global Focused Ultrasound Systems for Essential Tremor Sales volume, and how has it changed over the past five years?

What is Focused Ultrasound Systems for Essential Tremor price trend, what has been the historical prices?

What will be the Focused Ultrasound Systems for Essential Tremor price trend in 2025?

Which countries have the highest Focused Ultrasound Systems for Essential Tremor Sales, and what factors contribute to their dominance in the market?

How does Focused Ultrasound Systems for Essential Tremor Sales vary across key manufacturers, and what expansions have been observed recently?

What is the current global revenue generated from Focused Ultrasound Systems for Essential Tremor Sales, and how does it compare to previous years?

Which industries drive the highest demand for Focused Ultrasound Systems for Essential Tremor, and how is this demand expected to evolve in the next five years?

What are the major challenges impacting Focused Ultrasound Systems for Essential Tremor Sales and supply chain operations across key markets?

How do government policies, environmental regulations, and trade restrictions affect Focused Ultrasound Systems for Essential Tremor Sales and market dynamics?

Related Studies:

Scalp Cooling Systems for Chemotherapy Patients Market
https://datavagyanik.com/reports/scalp-cooling-systems-for-chemotherapy-patients-market/

PVA Embolization Particles Market
https://datavagyanik.com/reports/pva-embolization-particles-market/

Microwave Tumor Ablation System Market
https://datavagyanik.com/reports/microwave-tumor-ablation-system-market/

Tissue Contact Probe Ablators Market
https://datavagyanik.com/reports/tissue-contact-probe-ablators-market/

Tissue Spray Probe Ablators Market
https://datavagyanik.com/reports/tissue-spray-probe-ablators-market/

IT Park, Dehradun, UK

Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advisory to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis and competitive intelligence.

Contact us:

Peter (Sales Head)
Phone: +1-330-440-0311
Website: https://datavagyanik.com/
Linkedin: https://www.linkedin.com/company/datavagyanik-business-intelligence-solutions/Email: sales@datavagyanik.com

This release was published on openPR.